Prime Medicine, Inc. Cash and Short Term Investments

Cash and Short Term Investments of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash and Short Term Investments growth rates and interactive chart. Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities. Cash and short term investments are considered very liquid assets.

Highlights and Quick Summary

  • Cash and Short Term Investments for the quarter ending September 30, 2023 was $165 Million (a -20.37% decrease compared to previous quarter)
  • Year-over-year quarterly Cash and Short Term Investments decreased by -43.75%
  • Annual Cash and Short Term Investments for 2022 was $294 Million (a 9.01% increase from previous year)
  • Annual Cash and Short Term Investments for 2021 was $270 Million (a 405.59% increase from previous year)
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash and Short Term Investments of Prime Medicine, Inc.

Most recent Cash and Short Term Investmentsof PRME including historical data for past 10 years.

Interactive Chart of Cash and Short Term Investments of Prime Medicine, Inc.

Prime Medicine, Inc. Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $165.32 $207.62 $249.52 – –
2022 – – $293.92 $146.67 $293.92
2021 – – – – $269.62
2020 – – – – $53.33

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com